SDC1 and plasma cell myeloma: To confirm these data in an effector/target autologous setting, we carried out degranulation assays using as effectors CD138- cells isolated from BM aspirates of MM patients, untreated or treated with MLN4924 (150 nM) for 48 h and incubated with purified autologous myeloma target cells (CD138+ cells).